TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) - ANVISA Registration 82286660012

Access comprehensive regulatory information for TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 82286660012 and manufactured by manufacturer not specified. The registration is held by SIGNAZ PRODUTOS E NEGOCIOS LTDA with validity until Aug 11, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including BIO-RAD, QUIBASA QUÍMICA BÁSICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.